Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder.
Seval N, Frank CA, Litwin AH, Roth P, Schade MA, Pavlicova M, Levin FR, Brady KT, Nunes EV, Springer SA. Seval N, et al. Among authors: springer sa. Contemp Clin Trials. 2021 Jun;105:106394. doi: 10.1016/j.cct.2021.106394. Epub 2021 Apr 7. Contemp Clin Trials. 2021. PMID: 33838307 Free PMC article. Clinical Trial.
Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes.
Saber-Tehrani AS, Springer SA, Qiu J, Herme M, Wickersham J, Altice FL. Saber-Tehrani AS, et al. Among authors: springer sa. Contemp Clin Trials. 2012 Mar;33(2):436-44. doi: 10.1016/j.cct.2011.11.002. Epub 2011 Nov 12. Contemp Clin Trials. 2012. PMID: 22101218 Free PMC article. Clinical Trial.
Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.
Di Paola A, Lincoln T, Skiest DJ, Desabrais M, Altice FL, Springer SA. Di Paola A, et al. Among authors: springer sa. Contemp Clin Trials. 2014 Nov;39(2):256-68. doi: 10.1016/j.cct.2014.09.002. Epub 2014 Sep 18. Contemp Clin Trials. 2014. PMID: 25240704 Free PMC article. Clinical Trial.
Corrigendum to "Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community" [Contemp. Clin. Trials (2014) 209-218].
Springer SA, Altice FL, Herme M, Di Paola A. Springer SA, et al. Contemp Clin Trials. 2017 Jun;57:98. doi: 10.1016/j.cct.2017.03.008. Epub 2017 Mar 21. Contemp Clin Trials. 2017. PMID: 28341227 No abstract available.
Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.
Springer SA, Di Paola A, Azar MM, Barbour R, Biondi BE, Desabrais M, Lincoln T, Skiest DJ, Altice FL. Springer SA, et al. J Acquir Immune Defic Syndr. 2018 May 1;78(1):43-53. doi: 10.1097/QAI.0000000000001634. J Acquir Immune Defic Syndr. 2018. PMID: 29373393 Free PMC article. Clinical Trial.
147 results